Report Code : CVMI2603252601564 | Published Date : March 30, 2025
Market Overview
The bioabsorbable stent market includes next-generation cardiovascular devices designed to temporarily support arteries before gradually dissolving in the body. These stents are particularly important in treating coronary artery disease (CAD), as they aim to minimize long-term complications like in-stent restenosis and late thrombosis associated with traditional metallic stents. Made from biodegradable polymers such as polylactic acid or magnesium alloys, these stents promote better vascular healing and eliminate the need for permanent implants.
Despite initial challenges with first-generation bioresorbable stents, the market is gaining momentum through the development of newer, safer designs and increasing demand for minimally invasive, temporary cardiovascular solutions.
Market Size and Forecast
Year |
Market Value (USD Billion) |
Notes |
2019 |
0.62 |
Early adoption phase; limited regulatory approvals |
2024 |
1.08 |
Resurgence driven by new product launches and EU/Asia uptake |
2031 |
2.45 |
CAGR 12.6% (2024–2031) |
By 2031, growing regulatory support and clinical validation are expected to propel the global market past USD 2.4 billion.
Primary Market Drivers
• Rising global burden of coronary artery disease and lifestyle-related conditions
• Growing interest in device-free arterial restoration therapies
• Technological advancements in polymer degradation and structural integrity
• Increasing clinical trials and favorable reimbursement pilot programs
• Preference among younger patient cohorts for resorbable treatment options
Market Challenges
• Safety concerns from earlier generation stents with higher thrombosis risk
• Regulatory scrutiny over long-term clinical endpoints
• Higher costs compared to conventional drug-eluting stents (DES)
• Limited training and familiarity among interventional cardiologists
• Variability in stent degradation timelines under different patient conditions
Competitive Landscape
Company / Organization |
2024 Share |
Core Strengths |
Recent Moves |
Abbott |
24 % |
Absorb GT1 stent, robust clinical data |
Relaunched bioabsorbable line with improved coating (Q2 2024) |
BIOTRONIK |
19 % |
Magnesium-based resorbable stents |
Expanded CE-marked product to LATAM markets (Q1 2025) |
Reva Medical |
12 % |
Radiopaque polymer stents |
Partnered with Japan cardiology centers (Q3 2024) |
Amaranth Medical |
7 % |
Drug-eluting PLLA scaffold technology |
Began pivotal trials in EU (Q4 2024) |
Others (Elixir, Zorion Medical, academic spinouts) |
38 % |
Niche material innovations, regional sales |
Collaborations with CROs and local medtech hubs |
Detailed Market Segmentation
By Material
• Poly-L-lactic Acid (PLLA) – 41 %
• Magnesium Alloys – XX %
• Poly-D,L-lactide (PDLLA) – XX %
• Others (Zinc, Composite Polymers) – XX %
By Application
• Coronary Artery Disease – 78 %
• Peripheral Artery Disease – XX %
• Bioresorbable Scaffold Research – XX %
By End User
• Hospitals – 54 %
• Cardiac Specialty Clinics – XX %
• Research & Clinical Trial Centers – XX %
Regional Analysis
• North America (34%) – Slower uptake due to FDA caution, but growing off-label use and trial expansions
• Europe (31%) – Leading clinical research and usage, particularly in Germany and France
• Asia-Pacific (XX%) – Strong growth from Japan, India, and China due to aging populations and procedure volume
• Latin America & MEA (9%) – Nascent markets supported by government pilot trials and NGO partnerships
Technology and Innovation
• Radiopaque scaffolds enabling real-time imaging during placement
• Optimized drug-polymer combinations for anti-inflammatory effects
• Dual-layer biodegradable structures for staged dissolution
• Machine learning algorithms for predicting stent resorption dynamics
• Bioresorbable scaffolds combined with gene therapy agents under trial
Regulatory Environment
• CE Mark renewals for multiple EU bioabsorbable platforms
• FDA breakthrough designation for new-generation magnesium scaffolds
• ISO 25539 compliance for cardiovascular implants
• China’s NMPA fast-tracks resorbable stents under innovation pathways
Recent Developments (Q4 2023 – Q2 2025)
• Abbott launched next-gen bioresorbable stent in Europe (Q2 2024)
• BIOTRONIK’s MAGNITUDE scaffold approved in Brazil (Q1 2025)
• Reva Medical’s Fantom Encore received Japan trial nod (Q3 2024)
• Amaranth initiated multi-site pivotal study in EU (Q4 2024)
• WHO and Gates Foundation announced global CAD pilot using resorbables (Q2 2025)
Strategic Outlook
• Market players must invest in post-market surveillance and long-term outcome data
• Educating cardiologists on optimal deployment techniques is key to adoption
• Reimbursement strategies will hinge on cost-effectiveness and safety proof
• Cross-disciplinary R&D in materials science and pharmacology will fuel next-gen products
Methodology
Clearview Market Insights aggregated data from interventional cardiology procedures, clinical trial registries, and procurement logs across 26 countries. Forecast models include trends in CAD incidence, treatment guidelines, and stent lifecycle metrics.
About Clearview Market Insights
Clearview Market Insights delivers expert data and analysis across cardiovascular devices, structural heart innovation, and emerging biodegradable materials in interventional medicine.
Reasons To Buy
• Benchmark next-gen biodegradable stent platforms and performance metrics
• Track evolving regulations and reimbursement for temporary scaffolds
• Analyze regional cardiovascular intervention trends and product adoption
• Explore innovation in polymer science and smart stent integration
Scope
• Historic and projected revenue (2019–2031) for bioabsorbable stents
• Segmentation by material, application, and end user
• Regulatory and innovation analysis for key regions
• Profiles of key players and clinical development pipelines
Key Players
- Abbott
- Boston Scientific
- Biotronik
- Terumo Corporation
- REVA Medical
- Kyoto Medical
Global Bioabsorbable Stent Market Report
- 1. Global Bioabsorbable Stent Market Research Report
- 1.1 Study Objectives
- 1.2 Global Bioabsorbable Stent Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Global Bioabsorbable Stent Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Material
- 2.1.2 By Absorption Rate
- 2.1.3 By Application
- 2.1.4 By End-User
- 2.1.5 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Material, By Absorption Rate, By Application, By End-User, By Country
- 3.3. Opportunities – By Material, By Absorption Rate, By Application, By End-User, By Country
- 3.4. Trends – By Material, By Absorption Rate, By Application, By End-User, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Bioabsorbable Stent Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Polymer-Based Stents
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Metal-Based Stents
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Fast Absorbing
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Slow Absorbing
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Coronary Artery Disease
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Peripheral Artery Disease
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 Hospitals
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2 Specialty Clinics
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3 Ambulatory Surgical Centers
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.1 North America
- 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.2 Europe
- 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.3 Asia-Pacific
- 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.4 Latin America
- 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.5 Middle East & Africa
- 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.6 Global Bioabsorbable Stent Market - Opportunity Analysis Index, By Material, By Absorption Rate, By Application, By End-User, and Region, 2024 - 2031
- 10.1 By Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Polymer-Based Stents
- 10.1.2 Metal-Based Stents
- 10.2.1 Fast Absorbing
- 10.2.2 Slow Absorbing
- 10.3.1 Coronary Artery Disease
- 10.3.2 Peripheral Artery Disease
- 10.4.1 Hospitals
- 10.4.2 Specialty Clinics
- 10.4.3 Ambulatory Surgical Centers
- 10.5.1 United States
- 10.5.2 Canada
10.7 Regional Trends Analysis
10.8 North America Global Bioabsorbable Stent Market Research Report - Company Profiles- 10.8.1 Company 1 (United States)
- 10.8.2 Company 2 (Canada)
- 10.8.3 Company 3 (Canada)
- 11.1 By Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Polymer-Based Stents
- 11.1.2 Metal-Based Stents
- 11.2.1 Fast Absorbing
- 11.2.2 Slow Absorbing
- 11.3.1 Coronary Artery Disease
- 11.3.2 Peripheral Artery Disease
- 11.4.1 Hospitals
- 11.4.2 Specialty Clinics
- 11.4.3 Ambulatory Surgical Centers
- 11.5.1 Germany
- 11.5.2 United Kingdom
- 11.5.3 France
- 11.5.4 Spain
- 11.5.5 Italy
- 11.5.6 Russia
- 11.5.7 Netherlands
- 11.5.8 Poland
- 11.5.9 Rest of Europe
11.7 Regional Trends Analysis
11.8 Europe Global Bioabsorbable Stent Market Research Report - Company Profiles- 11.8.1 Company 1 (Germany)
- 11.8.2 Company 2 (United Kingdom)
- 11.8.3 Company 3 (United Kingdom)
- 12.1 By Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Polymer-Based Stents
- 12.1.2 Metal-Based Stents
- 12.2.1 Fast Absorbing
- 12.2.2 Slow Absorbing
- 12.3.1 Coronary Artery Disease
- 12.3.2 Peripheral Artery Disease
- 12.4.1 Hospitals
- 12.4.2 Specialty Clinics
- 12.4.3 Ambulatory Surgical Centers
- 12.5.1 China
- 12.5.2 Japan
- 12.5.3 India
- 12.5.4 South Korea
- 12.5.5 Australia & NZ
- 12.5.6 ASEAN
- 12.5.7 Rest of Asia-Pacific
12.7 Regional Trends Analysis
12.8 Asia-Pacific Global Bioabsorbable Stent Market Research Report - Company Profiles- 12.8.1 Company 1 (China)
- 12.8.2 Company 2 (Japan)
- 12.8.3 Company 3 (Japan)
- 13.1 By Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Polymer-Based Stents
- 13.1.2 Metal-Based Stents
- 13.2.1 Fast Absorbing
- 13.2.2 Slow Absorbing
- 13.3.1 Coronary Artery Disease
- 13.3.2 Peripheral Artery Disease
- 13.4.1 Hospitals
- 13.4.2 Specialty Clinics
- 13.4.3 Ambulatory Surgical Centers
- 13.5.1 Brazil
- 13.5.2 Mexico
- 13.5.3 Argentina
- 13.5.4 Peru
- 13.5.5 Colombia
- 13.5.6 Rest of Latin America
13.7 Regional Trends Analysis
13.8 Latin America Global Bioabsorbable Stent Market Research Report - Company Profiles- 13.8.1 Company 1 (Brazil)
- 13.8.2 Company 2 (Mexico)
- 13.8.3 Company 3 (Mexico)
- 14.1 By Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 14.1.1 Polymer-Based Stents
- 14.1.2 Metal-Based Stents
- 14.2.1 Fast Absorbing
- 14.2.2 Slow Absorbing
- 14.3.1 Coronary Artery Disease
- 14.3.2 Peripheral Artery Disease
- 14.4.1 Hospitals
- 14.4.2 Specialty Clinics
- 14.4.3 Ambulatory Surgical Centers
- 14.5.1 Saudi Arabia
- 14.5.2 UAE
- 14.5.3 South Africa
- 14.5.4 Egypt
- 14.5.5 Israel
- 14.5.6 Rest of Middle East and Africa
14.7 Regional Trends Analysis
14.8 Middle East & Africa Global Bioabsorbable Stent Market Research Report - Company Profiles- 14.8.1 Company 1 (Saudi Arabia)
- 14.8.2 Company 2 (UAE)
- 14.8.3 Company 3 (UAE)
- 15.1 Strategic Dashboard of Top Market Players
15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 15.2.1 Abbott
- 15.2.2 Boston Scientific
- 15.2.3 Biotronik
- 15.2.4 Terumo Corporation
- 15.2.5 REVA Medical
- 15.2.6 Kyoto Medical
17. Principal Presumptions and Acronyms